- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Dermatology pioneer Aaron Lerner, Yale chairman, dies at 86
New Haven, Conn. - Aaron Lerner, M.D., a native Minnesotan and Yale University School of Medicine professor whose research led to treatments for skin diseases, died Feb. 3 of complications from Parkinson’s disease in New Haven, Conn., the Minneapolis Star Tribune reports. He was 86.
New Haven, Conn. - Aaron Lerner, M.D., a native Minnesotan and Yale University School of Medicine professor whose research led to treatments for skin diseases, died Feb. 3 of complications from Parkinson’s disease in New Haven, Conn., the Minneapolis Star Tribune reports. He was 86.
Dr. Lerner was the first chairman of Yale’s dermatology department, from 1958 to 1985. He retired in 1990, but was a professor emeritus until his death. Among his contributions were his leadership of a team that discovered the hormone melatonin in the 1950s and his development of a transplantation therapy for vitiligo.
A memorial service will be held at Yale on March 21.
